Outline
| Key Fields |
Basic Research for Medical Innovation
|
| R&D phase |
Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study
|
| Contact |
-
Division of Research Programs, Department of International Strategy
- TEL: +81-3-6870-2216
- E-mail: sicorp”at”amed.go.jp(Replace “at” with @)
|
The aim of this program is to contribute solutions to challenges facing world today and to bolster Japan’s scientific and technological capabilities through collaboration with a broad range of countries．
This program provides support for international joint research projects on the basis of equal partnership in countries，regions，and fields of cooperation that have been designated as particularly important by the Ministry of Education，Culture，Sports，Science and Technology(MEXT)on the basis of intergovernmental agreements，in collaboration with funding agencies in the countries concerned．
Implementing Body
SICORP(South Africa)
- Research Area– “Genomic Insights into the Pathogenesis of Cancer and Infectious Diseases”
- South Africa and Japan aim to strengthen bilateral collaboration in medical research, focusing on genomics-based studies of cancer and infectious diseases, and seek innovative solutions to global health challenges while boosting scientific and technological capabilities through collaborative efforts.
- Funding Agency of South Africa Side
- South African Medical Research Council
- Duration:FY2025-FY2028
| Project Title |
Deciphering synergistic interactions between HIV and EBV in lymphomagenesis through genomic and transcriptomic analyses |
| Country |
Japan |
South Africa |
| PI |
Dr. SATO Yoshitaka |
Dr. Shaheen Mowla |
| Affiliation |
Nagoya University |
University of Cape Town |
| Project Title |
Discovery and validation of new host-directed drug targets for tuberculosis in human macrophages |
| Country |
Japan |
South Africa |
| PI |
Dr. SUZUKI Harukazu |
Dr. Suraj Parihar |
| Affiliation |
RIKEN |
University of Cape Town |
| Project Title |
CeCa for Precision medicine: Elucidating the cervical cancer malignancy mechanisms for precise treatment based on genome comparison and drug sensitivity test of Japanese and South African patient sample |
| Country |
Japan |
South Africa |
| PI |
Dr. YAMAMOTO Yusuke |
Dr. Deepak Balaji Thimiri Govindaraj |
| Affiliation |
National Cancer Center |
The Council for Scientific and Industrial Research (CSIR) |
SICORP(Singapore)
- Research Area– “Cancer Complexity”
- The aim of the collaborative project is to strengthen collaborations between Japan and Singapore in the biomedical field and promote research and development, leveraging strengths of researchers in both countries.
- Funding Agency of Singapore Side
- Agency for Science, Technology and Research (A*STAR)
- Duration:FY2023-FY2026
| Project Title |
Epigenomic Impacts by Asian-prevalent Carcinogens in the Evolution and Complexity of Asian Cancers |
| Country |
Japan |
Singapore |
| PI |
Dr. KANEDA Atsushi |
Dr. Bin Tean Teh |
| Affiliation |
Chiba University |
National Cancer Centre Singapore |
| Project Title |
Elucidating the roles of intra- and extracellular effectors of cancer as modulators of the immune system |
| Country |
Japan |
Singapore |
| PI |
Dr. KONDO Yutaka |
Dr. Shyam Prabhakar |
| Affiliation |
Nagoya University |
A*STAR Genome Institute of Singapore |
SICORP(Australia)
- Research Area – "Research and development on the prevention, diagnosis and/or treatment of dementia"
- The aim of the collaborative project is to deliver research funding for internationally competitive and innovative collaborations between early career researchers and established researchers from Australia and Japan in the field of dementia research.
- Funding Agency of Australia Side
- The National Health and Medical Research Council (NHMRC)
- Duration: FY2023-FY2025
| Project Title |
Exploring biomarkers, therapeutic targets, and modifiable risk factors for non-Alzheimer dementia |
| Country |
Japan |
Australia |
| PI |
Dr. KIKKAWA Takako |
Dr. Yijun Pan |
| Affiliation |
Tohoku University |
The University of Melbourne
Florey Institute of Neuroscience and Mental Health |
Results Report
Management and Evaluation Framework
PS(Program Supervisor)
USHIJIMA Toshikazu, M.D., Ph.D., President, Hoshi University
PO(Program Officer)
SICORP(Australia)
IWATSUBO Takeshi, M.D., Ph.D., Director of the National Institute of Neuroscience, National Center of Neurology and Psychiatry
SICORP(Singapore)
KIYONO Tohru, M.D., Ph.D., Visiting Scientist, Sasaki Institute, Sasaki Foundation
SICORP(South Africa)
FUJIMOTO Akihiro, Ph.D., Professor, Graduate School of Medicine, The University of Tokyo
